by David Kent | Jun 24, 2016
The 2016 Annual Meeting of the International Society for Stem Cell Research got off to a fantastic start Wednesday night in San Francisco. Two excellent sessions were delivered to a packed house with talks ranging from the importance of circular RNAs (Pier Paolo...
by Jovana Drinjakovic | Jun 13, 2016
When Dr. Andras Nagy, a Senior Scientist at Sinai Health System’s Lunenfeld-Tanenbaum Research Institute in Toronto, set out to catalogue molecular events behind reprogramming — a process of making stem cells in a dish — he did not expect to uncover a new kind...
by Samantha Payne | Jun 7, 2016
The World Biomaterials Congress (WBC), which takes place once every four years, happened last month. Among the many excellent presentations at WBC, two themes related to cell-based therapies stood out: 1) the use of biomaterials to study cell behaviour and...
by Paul Krzyzanowski | May 25, 2016
A few weeks ago, I came across an interesting story about a stem cell company with a peculiar patenting strategy. As I looked into it further, I realized I’d stumbled into a complicated corporate plot that became more incredible with every turn. Endonovo Therapeutics...
by Holly Wobma | May 16, 2016
At the crossroad of developmental biology and tissue engineering, there is a group of scientists trying to delicately coax stem cells down a specific path. In the metaphoric sense, they are most interested in how the nature of their cells evolves over time. But what...
Comments